On the upside
Shares of Acorda Therapeutics (Nasdaq: ACOR) soared after the FDA gave the company's multiple sclerosis treatment a positive review.
Rubio's Restaurant (Nasdaq: RUBO) received an $80 million unsolicited offer from a private equity firm.
Solta Medical (Nasdaq: SLTM) received FDA approval for its laser treatment that removes pigments.
On the downside
Citigroup (NYSE: C) and Goldman Sachs (NYSE: GS) reported revenues and profits that beat targets, but investor expectations were much higher after yesterday's robust quarterly earnings by JPM Morgan Chase (NYSE: JPM).
Nokia (NYSE: NOK) posted a loss due to a significant write-down of a joint venture with Siemens and falling smartphone handset sales.
Crown Holdings (NYSE: CCK) posted lower profits as food and drink packaging revenues fell.
In the broad market, declining issues outpaced advancers by a margin of nearly 2 to 1 on the NYSE and by more than 2 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks lost 2 points to 621.
